.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,300,674

« Back to Dashboard

Claims for Patent: 7,300,674

Title:Sterile low bicarbonate dialysis concentrate solutions
Abstract:The present invention relates to a sterile calcium-free low bicarbonate dialysis concentrate composition for use in conjunction with regional citrate anti-coagulation in the context of either dialysis or hemofiltration. Methods of use of the sterile calcium free low bicarbonate dialysis concentrate compositions are also disclosed. The low bicarbonate concentrate takes into account the fact that citrate is hepatically metabolized into bicarbonate, thus minimizing metabolic complications.
Inventor(s): Tobe; Sheldon (Toronto, Ontario, CA)
Assignee:
Application Number:10/020,882
Patent Claims: 1. A sterile calcium free low bicarbonate dialysis concentrate composition containing sodium chloride, magnesium chloride and sodium bicarbonate for continuous renal replacement therapy and for use in the preparation of a sterile calcium free dialysis solution comprising sodium chloride (NaCl), magnesium chloride (MgCl.sub.2), and a concentration of sodium bicarbonate (NaHCO.sub.3) sufficiently low so as to allow preparation of the sterile calcium free dialysis solution for continuous renal replacement therapy, having ion concentrations of Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 116.5.+-.11 mmol/l, and HCO.sub.3 25.0.+-.2.5 mmol/l.

2. A sterile calcium free low bicarbonate dialysis concentrate composition containing sodium chloride, magnesium chloride and sodium bicarbonate for continuous renal replacement therapy and for use in the preparation of a sterile calcium free dialysis solution comprising sodium chloride (NaCl), magnesium chloride (MgCl.sub.2), and a concentration of sodium bicarbonate (NaHCO.sub.3) sufficiently low so as to allow preparation of the sterile calcium free dialysis solution for continuous renal replacement therapy, having ion concentrations of Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, 01116.5.+-.11 mmol/l, and HCO.sub.3 of from 20 to less than 30 mmol/l.

3. A kit for preparing a sterile calcium free dialysis solution comprising the sterile calcium free dialysis concentrate composition of claim 1 or 2 and optionally instructions for use.

4. The kit of claim 3, further comprising sterile water sufficient to dilute the concentrate to a sterile calcium free dialysis solution comprising Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 116.5.+-.11 mmol/l, and HCO.sub.3 25.0.+-.2.5 mmol/l.

5. A method of preparing a sterile calcium free dialysis solution comprising diluting a sterile calcium free dialysis concentrate composition of claim 1 or 2 in a sufficient amount of sterile water to prepare a sterile calcium free dialysis solution comprising Na .140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 116.5.+-.11 mmol/l, and HCO.sub.3 25.0.+-.2.5 mmol/l.

6. A method for providing continuous renal replacement therapy to a patient comprising administering a sterile calcium free dialysis solution prepared according to the method of claim 5 in conjunction with a regional citrate anti-coagulant solution to a patient in need thereof.

7. A method of preparing a sterile calcium free dialysis solution or infusate comprising diluting a sterile calcium free dialysis concentrate composition of claim 1 or 2 in a sufficient amount of sterile water to prepare a sterile calcium free dialysis solution or infusate comprising Na 140.+-.14 mmol/l, Mg 0.75.+-.0.07 mmol/l, Cl 116.5.+-.11 mmol/l, and HCO.sub.3 25.0.+-.2.5 mmol/l.

8. A method for treating acute renal failure in a critically ill patient without introducing calcium into the blood removed from the patient during dialysis comprising administering a sterile calcium free dialysis solution prepared according to the method of claim 7 in conjunction with a regional citrate anti-coagulant solution to a patient in need thereof.

9. A method for providing hemofiltration to a patient comprising administering a sterile calcium free infusate prepared according to the method of claim 7 in conjunction with a regional citrate anti-coagulant solution to a patient in need thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc